<DOC>
	<DOCNO>NCT02504775</DOCNO>
	<brief_summary>This monocentric , single blind , randomize , single-dose , two-periods , two-sequence , crossover bioequivalence study two oral formulation healthy participant fast condition .</brief_summary>
	<brief_title>Bioequivalence Study Mejoral 500 Product</brief_title>
	<detailed_description />
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Understanding study procedure , restriction willingness participate evidenced voluntary write informed consent Men woman 18 55 year age , good state health Participants ' body mass index must 18.0 27.0 Blood pressure ( seat ) 139 milliliter mercury ( mm/Hg ) systolic 89 mm/Hg diastolic , heart rate 60 100 beat per minute respiratory frequency 14 20 breath per minute The laboratory test : Complete blood count differential count , Chemical blood 27 element , Urinalysis , NonReactive Antihepatitis B virus ( HBV ) hepatitis B Antihepatitis C antibody ( HCV ) hepatitis C , NonReactive Human immunodeficiency virus ( HIV ) test , Negative Venereal Disease Research Laboratory ( VDRL ) test maximum 3 month validity allow variation +/10 % normal range Electrocardiogram ( ECG ) three month validity clinically significant finding Pregnancy test , drug abuse test alcohol test negative result selection visit approximately 12 h drug product administration study period Participants alteration vital sign ; fail comply propose inclusion criterion Participants history suffer cardiovascular , renal , hepatic , muscle , metabolic , gastrointestinal , neurological problem , endocrine , hematopoietic type anemia , asthma , mental illness organic abnormality . Participants muscle injury within 21 day prior study Clinically significant abnormality ECG , dyspepsia , gastritis , esophagitis , gastric duodenal ulcer ; participant require drug product test product course study Exposed inductor liver enzyme inhibitor drug capable alter urinary pH potentially toxic drug , vitamin , herbal remedy within 30 day prior begin study Participant hospitalize problem seven month prior study start ; receive investigational product within 90 day prior study Allergic drug product , food substance , require special diet ; positive drug abuse , alcohol , pregnancy test , breast feeding woman Donated lose 450 milliliter ( mL ) blood within 60 day prior begin study Participants record Federal Commission Protection Sanitary Risks ( COFEPRIS ) page Ingested alcohol , carbonate beverage , product contain xanthine , charcoal grill nourishment , grapefruit orange smoke 24 h prior begin study period Subordination relationship participant investigator , employee sponsor study site member immediate family</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>